...
首页> 外文期刊>Archives of rheumatology. >Blocking TNF-α in Complex Regional Pain Syndrome Type I: A Case of Reflex Sympathetic Dystrophy Resolved with Etanercept in a Patient with Ankylosing Spondylitis
【24h】

Blocking TNF-α in Complex Regional Pain Syndrome Type I: A Case of Reflex Sympathetic Dystrophy Resolved with Etanercept in a Patient with Ankylosing Spondylitis

机译:I型复杂区域疼痛综合征中阻断TNF-α:强直性脊柱炎患者使用依那西普解决的反射性交感神经营养不良一例

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Complex regional pain syndrome type I (CRPS1) is apainful clinical condition that may develop mostly as a resultof trauma affecting the limbs. Hyperalgesia, allodynia,spontaneous pain, and autonomic disturbances alongwith swelling and impairment of motor functions are thehallmarks. Ultimately, this syndrome may lead to disability.Although many different kinds of treatments have beentried, the success of these treatments has been limited.Inflammatory signs appear especially in the early andmid-stages of the disease. These findings may favor theuse of new treatment modalities including the use of newgeneration medicines like monoclonal antibodies in thetreatment of CRPS. In this article, we report the completeresolution of CRPS1 with the TNF-a-blocker etanercept ina 62-year-old female patient with ankylosing spondylitis.
机译:I型复杂性局部疼痛综合征(CRPS1)是一种微弱的临床疾病,可能主要是由于四肢创伤造成的。痛觉过敏,异常性疼痛,自发性疼痛和自主神经紊乱以及肿胀和运动功能受损是其特征。最终,这种综合征可能导致残疾。尽管尝试了许多不同的治疗方法,但这些治疗方法的成功受到了限制。炎症迹象特别是在疾病的早期和中期出现。这些发现可能有利于使用新的治疗方式,包括在CRPS的治疗中使用诸如单克隆抗体之类的新一代药物。在本文中,我们报道了62岁的强直性脊柱炎女性患者使用TNF-α阻断剂etanercept完全缓解了CRPS1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号